CorMedix (CRMD) Revenue (2013 - 2025)

CorMedix (CRMD) reported Revenue of $128.6 million for Q4 2025, up 312.1% on a YoY basis from $31.2 million in Q4 2024, and up 23.34% sequentially from $104.3 million in Q3 2025.

CorMedix (CRMD) Revenue (2013 - 2025) Analysis & Trends

CorMedix (CRMD) has 12 years of Revenue data on file, last reported at $128.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 312.1% year-over-year to $128.6 million; the trailing twelve-month figure through Dec 2025 stood at $311.7 million (up 616.54% YoY), and the FY2025 full-year result was $311.7 million, up 617.03% from the prior year.
  • Revenue advanced to $128.6 million in Q4 2025, from $104.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $128.6 million in Q4 2025 to a low of $6817.0 in Q3 2022.
  • A 4-year average of $23.7 million and a median of $88261.0 in 2021 frame the typical range for Revenue.
  • Across the five-year window, Revenue sank 91.35% in 2022 and surged 4829.4% in 2025, its largest moves.
  • Tracing CRMD's Revenue over 4 years: stood at $56397.0 in 2021, then slumped by 47.33% to $29702.0 in 2022, then jumped by 104976.31% to $31.2 million in 2024, then surged by 312.1% to $128.6 million in 2025.
  • Business Quant data shows CRMD's Revenue at $128.6 million in Q4 2025, $104.3 million in Q3 2025, and $39.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn 128.62 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 128.62 Mn
Sep 30, 2025 104.28 Mn
Jun 30, 2025 39.74 Mn
Mar 31, 2025 39.08 Mn
Dec 31, 2024 31.21 Mn
Sep 30, 2024 11.46 Mn
Jun 30, 2024 806,119.00
Dec 31, 2022 29,702.00
Sep 30, 2022 6,817.00
Jun 30, 2022 21,253.00
Mar 31, 2022 7,636.00
Dec 31, 2021 56,397.00
Sep 30, 2021 38,088.00
Jun 30, 2021 8,191.00
Mar 31, 2021 88,261.00
Dec 31, 2020 55,714.00
Sep 30, 2020 93,020.00
Jun 30, 2020 16,443.00
Mar 31, 2020 74,054.00
Dec 31, 2019 24,778.00